Sign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
Corporate

Insider Transactions

Showing insider trading activity for Sorrento Therapeutics, Inc..

Insider Trading Activity Chart

Visualizing insider transactions on stock price candles

Transaction Type
Insider Role
Min Transaction Value

No stock price data available.

Recent Filings
SymbolNameFiledTransactionTypeRoleShares
CELUSorrento Therapeutics, Inc.5 Oct 202329 Sept 2023S-Sale10 percent owner9,064,539
CELUWSorrento Therapeutics, Inc.5 Oct 202329 Sept 2023S-Sale10 percent owner9,064,539
CELUSorrento Therapeutics, Inc.5 Oct 20235 Oct 2023S-Sale10 percent owner6,307,158
CELUWSorrento Therapeutics, Inc.5 Oct 20235 Oct 2023S-Sale10 percent owner6,307,158
VCKASorrento Therapeutics, Inc.25 Sept 202321 Sept 2023S-Sale10 percent owner60,068,585
SCLXSorrento Therapeutics, Inc.25 Sept 202321 Sept 2023S-Sale10 percent owner60,068,585
SCLXWSorrento Therapeutics, Inc.25 Sept 202321 Sept 2023S-Sale10 percent owner60,068,585
VCKAWSorrento Therapeutics, Inc.25 Sept 202321 Sept 2023S-Sale10 percent owner60,068,585
SCLXSorrento Therapeutics, Inc.25 Sept 202321 Sept 2023S-Sale10 percent owner4,490,617
VCKASorrento Therapeutics, Inc.25 Sept 202321 Sept 2023S-Sale10 percent owner4,490,617
VCKAWSorrento Therapeutics, Inc.25 Sept 202321 Sept 2023S-Sale10 percent owner4,490,617
SCLXWSorrento Therapeutics, Inc.25 Sept 202321 Sept 2023S-Sale10 percent owner4,490,617
VCKASorrento Therapeutics, Inc.23 Jan 202319 Jan 2023J-Otherdirector73,740,795
VCKAWSorrento Therapeutics, Inc.23 Jan 202319 Jan 2023J-Otherdirector73,740,795
SCLXSorrento Therapeutics, Inc.23 Jan 202319 Jan 2023J-Otherdirector73,740,795
SCLXWSorrento Therapeutics, Inc.23 Jan 202319 Jan 2023J-Otherdirector73,740,795
VCKAWSorrento Therapeutics, Inc.2 Dec 20222 Dec 2022P-Purchasedirector224,841
VCKASorrento Therapeutics, Inc.2 Dec 20222 Dec 2022P-Purchasedirector224,841
SCLXSorrento Therapeutics, Inc.2 Dec 20222 Dec 2022P-Purchasedirector224,841
VCKASorrento Therapeutics, Inc.25 Nov 202225 Nov 2022P-Purchasedirector46,172